Global Non-Invasive Prenatal Testing (Nipt) Market
Report Highlights
Non-Invasive Prenatal Testing (NIPT) Market Size And Forecast
According to Verified Market Research, The Global Non Invasive Prenatal Testing (NIPT)Market was valued at USD 2.00 billion in 2019 and is projected to reach USD 6.17 billion by 2027, growing at a CAGR of 16.32% from 2020 to 2027.
Global Non-Invasive Prenatal Testing (NIPT) Market Outlook
As technology improves and the cost of genetic testing decreases, researchers expect that NIPT will become available for many more genetic conditions. With NIPT becoming available in more and more areas, there is a significant commercial drive that is expected to aid the growth of the market in the forecast years.
Global Non-Invasive Prenatal Testing (NIPT) Market Competitive Landscape
The Global Non-Invasive Prenatal Testing (NIPT) Market is highly fragmented with the presence of a large number of players in the Global Market. Some of the major companies include Natera, Inc., Beijing Genomics Institute, Illumina, Inc., Laboratory Corporation of America Holdings, F. Hoffman-La Roche Ltd., Yourgene Health, Perkinelmer, Inc., and Agilent Technologies, Inc.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.